BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
calcium channel activity
,
Arthritis
,
Lymphocyte
,
Autoimmunity
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tumour protein p63
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Vulva
Skin
Mammary gland
Penis
Bladder
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Ectrodactyly
Amelia
Genodermatosis
Chronic interstitial cystitis
Sendai virus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
COOH-terminal signal transamidase
homoharringtonine
COH29
estradiol-17 beta-benzoate
stearic acid
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
IFNK
RNPC3
AGO1
GHR
FOXC2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Mouse Phenotypes - Ectodermal dysplasia
Adipocyte profiling analyses of Selective PPARg Modulators and full PPARg agonists
OMIM - Congenital disorder
Metastatic and primary breast tumors
OMIM - Congenital anomaly of digit
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Tumour protein p63
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed…
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamo…
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Th…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ